![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (S)-AMPA | increases activity | EXP | | 6480464 | alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid results in increased activity of ADORA2B protein | CTD | PMID:16601261 | (S)-AMPA | multiple interactions | EXP | | 6480464 | [isoalloxazine binds to and results in decreased activity of ADORA2B protein] which results in decreased susceptibility to alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid, isoalloxazine inhibits the reaction [alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid results in increased activity of ADORA2B protein] | CTD | PMID:16601261 | (S)-amphetamine | decreases expression | ISO | RGD:731020 | 6480464 | Dextroamphetamine results in decreased expression of ADORA2B mRNA | CTD | PMID:12205029 | (S)-amphetamine | multiple interactions | ISO | RGD:731020 | 6480464 | SOD1 inhibits the reaction [Dextroamphetamine results in decreased expression of ADORA2B mRNA] | CTD | PMID:12205029 | 1,7-dimethylxanthine | multiple interactions | ISO | RGD:731019 | 6480464 | ADORA2B mutant form inhibits the reaction [1 more ... | CTD | PMID:22701600 | 1-chloro-2,4-dinitrobenzene | increases expression | ISO | RGD:731019 | 6480464 | Dinitrochlorobenzene results in increased expression of ADORA2B mRNA | CTD | PMID:16314067 | 17beta-estradiol | multiple interactions | ISO | RGD:731019 | 6480464 | [Estradiol co-treated with TGFB1 protein] results in decreased expression of ADORA2B mRNA, Estradiol promotes the reaction [ESR2 protein results in decreased expression of ADORA2B mRNA] | CTD | PMID:20404318, PMID:30165855 | 17beta-estradiol | increases expression | ISO | RGD:731019 | 6480464 | Estradiol results in increased expression of ADORA2B mRNA | CTD | PMID:31614463 | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Estradiol] results in increased expression of ADORA2B mRNA | CTD | PMID:26496021 | 17beta-estradiol | multiple interactions | ISO | RGD:731020 | 6480464 | [Estradiol co-treated with Progesterone] results in increased expression of ADORA2B mRNA | CTD | PMID:19693291 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:731019 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Cycloheximide] results in increased expression of ADORA2B mRNA | CTD | PMID:19684285 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:731020 | 6480464 | Tetrachlorodibenzodioxin affects the expression of ADORA2B mRNA | CTD | PMID:21570461, PMID:26377647 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ADORA2B mRNA | CTD | PMID:21724226 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of ADORA2B mRNA | CTD | PMID:22298810 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:731019 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of ADORA2B mRNA | CTD | PMID:19684285 | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | RGD:731019 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ADORA2B mRNA | CTD | PMID:28628672 | 3H-1,2-dithiole-3-thione | increases expression | EXP | | 6480464 | 1, 2-dithiol-3-thione results in increased expression of ADORA2B mRNA | CTD | PMID:19162173 | 4-hydroxynon-2-enal | decreases expression | ISO | RGD:731020 | 6480464 | 4-hydroxy-2-nonenal results in decreased expression of ADORA2B mRNA | CTD | PMID:19191707 | 4-hydroxyphenyl retinamide | increases expression | ISO | RGD:731020 | 6480464 | Fenretinide results in increased expression of ADORA2B mRNA | CTD | PMID:28973697 | 4-tert-butylphenol | increases expression | ISO | RGD:731019 | 6480464 | butylphen results in increased expression of ADORA2B mRNA | CTD | PMID:10571726 | 5'-S-methyl-5'-thioadenosine | multiple interactions | ISO | RGD:731020 | 153297773 | 5'-S-methyl-5'-thioadenosine enhances the reaction [lipopolysaccharide increases expression of Adora2b mRNA in mouse liver myofibroblasts] | RGD | | acetamide | increases expression | EXP | | 6480464 | acetamide results in increased expression of ADORA2B mRNA | CTD | PMID:31881176 | acrylamide | increases expression | EXP | | 6480464 | Acrylamide results in increased expression of ADORA2B mRNA | CTD | PMID:28959563 | adenosine | affects response to substance | ISO | RGD:731020 | 6480464 | ADORA2B protein affects the susceptibility to Adenosine | CTD | PMID:16920807 | aflatoxin B1 | affects expression | ISO | RGD:731019 | 6480464 | Aflatoxin B1 affects the expression of ADORA2B protein | CTD | PMID:20106945 | aflatoxin B1 | increases expression | ISO | RGD:731019 | 6480464 | Aflatoxin B1 results in increased expression of ADORA2B mRNA | CTD | PMID:22100608, PMID:32234424 | all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of ADORA2B mRNA | CTD | PMID:20488242 | all-trans-retinoic acid | decreases expression | ISO | RGD:731019 | 6480464 | Tretinoin results in decreased expression of ADORA2B mRNA | CTD | PMID:23724009 | alloxazine | multiple interactions | EXP | | 6480464 | [isoalloxazine binds to and results in decreased activity of ADORA2B protein] which results in decreased susceptibility to alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid more ... | CTD | PMID:16601261 | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of ADORA2B mRNA | CTD | PMID:16483693 | BAY 60-6583 | multiple interactions | EXP | | 6480464 | BAY 60-6583 binds to and results in increased activity of ADORA2B protein | CTD | PMID:19749167 | BAY 60-6583 | multiple interactions | ISO | RGD:731020 | 6480464 | BAY 60-6583 promotes the reaction [Ethanol results in increased expression of ADORA2B mRNA], BAY 60-6583 promotes the reaction [Ethanol results in increased expression of ADORA2B protein] | CTD | PMID:35143882 | BAY 60-6583 | increases expression | ISO | RGD:731020 | 6480464 | BAY 60-6583 results in increased expression of ADORA2B mRNA, BAY 60-6583 results in increased expression of ADORA2B protein | CTD | PMID:35143882 | benzo[a]pyrene | increases expression | ISO | RGD:731020 | 6480464 | Benzo(a)pyrene results in increased expression of ADORA2B mRNA | CTD | PMID:23735875 | benzo[a]pyrene | increases methylation | ISO | RGD:731019 | 6480464 | Benzo(a)pyrene results in increased methylation of ADORA2B promoter | CTD | PMID:27901495 | benzo[a]pyrene | increases expression | ISO | RGD:731019 | 6480464 | Benzo(a)pyrene results in increased expression of ADORA2B mRNA | CTD | PMID:20064835 more ... | benzo[a]pyrene diol epoxide I | decreases expression | ISO | RGD:731019 | 6480464 | 7 more ... | CTD | PMID:20382639 | bis(2-ethylhexyl) phthalate | increases expression | EXP | | 6480464 | Diethylhexyl Phthalate results in increased expression of ADORA2B mRNA | CTD | PMID:20920545 | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Estradiol] results in increased expression of ADORA2B mRNA | CTD | PMID:26496021 | bisphenol A | decreases methylation | ISO | RGD:731019 | 6480464 | bisphenol A results in decreased methylation of ADORA2B gene | CTD | PMID:31601247 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of ADORA2B mRNA | CTD | PMID:30816183 | bisphenol A | multiple interactions | ISO | RGD:731019 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ADORA2B mRNA | CTD | PMID:28628672 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of ADORA2B mRNA | CTD | PMID:25181051 | bromobenzene | decreases expression | EXP | | 6480464 | bromobenzene results in decreased expression of ADORA2B mRNA | CTD | PMID:32479839 | butan-1-ol | multiple interactions | ISO | RGD:731019 | 6480464 | [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of ADORA2B mRNA | CTD | PMID:29432896 | cadmium atom | increases expression | ISO | RGD:731019 | 6480464 | Cadmium results in increased expression of ADORA2B mRNA | CTD | PMID:21172416 | cadmium dichloride | decreases expression | EXP | | 6480464 | Cadmium Chloride results in decreased expression of ADORA2B mRNA | CTD | PMID:25993096 | caffeine | multiple interactions | ISO | RGD:731019 | 6480464 | ADORA2B mutant form inhibits the reaction [Caffeine results in decreased expression of and results in decreased activity of HSD11B2 protein], ADORA2B mutant form inhibits the reaction [Caffeine results in decreased expression of HSD11B2 mRNA] | CTD | PMID:22701600 | caffeine | decreases expression | EXP | | 6480464 | Caffeine results in decreased expression of ADORA2B mRNA | CTD | PMID:26367767 | calcitriol | multiple interactions | ISO | RGD:731019 | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of ADORA2B mRNA | CTD | PMID:21592394 | calcitriol | decreases expression | ISO | RGD:731019 | 6480464 | Calcitriol results in decreased expression of ADORA2B mRNA | CTD | PMID:21592394 | carbon nanotube | affects expression | ISO | RGD:731020 | 6480464 | Nanotubes, Carbon affects the expression of ADORA2B mRNA | CTD | PMID:23845593 | carbon nanotube | increases expression | ISO | RGD:731020 | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | cerium trichloride | decreases expression | ISO | RGD:731020 | 6480464 | cerous chloride results in decreased expression of ADORA2B mRNA | CTD | PMID:23573234 | CGP 52608 | multiple interactions | ISO | RGD:731019 | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to ADORA2B gene] | CTD | PMID:28238834 | choline | multiple interactions | ISO | RGD:731020 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ADORA2B mRNA | CTD | PMID:20938992 | cisplatin | affects response to substance | ISO | RGD:731019 | 6480464 | ADORA2B protein affects the susceptibility to Cisplatin | CTD | PMID:16217747 | cisplatin | multiple interactions | ISO | RGD:731019 | 6480464 | [Cisplatin co-treated with jinfukang] results in increased expression of ADORA2B mRNA | CTD | PMID:27392435 | cobalt atom | multiple interactions | ISO | RGD:731019 | 6480464 | [tungsten carbide co-treated with Cobalt] results in increased expression of ADORA2B mRNA | CTD | PMID:18078969 | cocaine | affects expression | EXP | | 6480464 | Cocaine affects the expression of ADORA2B mRNA | CTD | PMID:20187946 | copper(II) sulfate | decreases expression | ISO | RGD:731019 | 6480464 | Copper Sulfate results in decreased expression of ADORA2B mRNA | CTD | PMID:19549813 | crocidolite asbestos | affects expression | ISO | RGD:731019 | 6480464 | Asbestos, Crocidolite affects the expression of ADORA2B mRNA | CTD | PMID:17331233 | Cuprizon | increases expression | EXP | | 6480464 | Cuprizone results in increased expression of ADORA2B mRNA | CTD | PMID:26577399, PMID:27523638 | cycloheximide | multiple interactions | ISO | RGD:731019 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Cycloheximide] results in increased expression of ADORA2B mRNA | CTD | PMID:19684285 | cyclosporin A | increases expression | ISO | RGD:731019 | 6480464 | Cyclosporine results in increased expression of ADORA2B mRNA | CTD | PMID:20106945 | cyclosporin A | decreases expression | ISO | RGD:731020 | 6480464 | Cyclosporine results in decreased expression of ADORA2B mRNA | CTD | PMID:26311998 | dexamethasone | multiple interactions | ISO | RGD:731019 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ADORA2B mRNA | CTD | PMID:28628672 | dextran sulfate | multiple interactions | ISO | RGD:731020 | 6480464 | [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] affects the expression of ADORA2B mRNA | CTD | PMID:29950665 | diazinon | increases methylation | ISO | RGD:731019 | 6480464 | Diazinon results in increased methylation of ADORA2B gene | CTD | PMID:22964155 | diclofenac | increases expression | ISO | RGD:731020 | 6480464 | Diclofenac results in increased expression of ADORA2B mRNA | CTD | PMID:26934552 | dioxygen | multiple interactions | ISO | RGD:731020 | 6480464 | [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ADORA2B mRNA | CTD | PMID:30529165 | diquat | increases expression | ISO | RGD:731019 | 6480464 | Diquat results in increased expression of ADORA2B mRNA | CTD | PMID:21172416 | dorsomorphin | multiple interactions | ISO | RGD:731019 | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | DPCPX | affects binding | ISO | RGD:731019 | 6480464 | 1, 3-dipropyl-8-cyclopentylxanthine binds to ADORA2B protein | CTD | PMID:21186795 | entinostat | multiple interactions | ISO | RGD:731019 | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ADORA2B mRNA | CTD | PMID:27188386 | entinostat | increases expression | ISO | RGD:731019 | 6480464 | entinostat results in increased expression of ADORA2B mRNA | CTD | PMID:26272509, PMID:27188386 | ethanol | increases expression | ISO | RGD:731020 | 6480464 | Ethanol results in increased expression of ADORA2B mRNA, Ethanol results in increased expression of ADORA2B protein | CTD | PMID:35143882 | ethanol | multiple interactions | ISO | RGD:731020 | 6480464 | ADORA2B protein inhibits the reaction [Ethanol results in increased expression of and results in increased secretion of IL1B protein] more ... | CTD | PMID:35143882 | ferric oxide | increases expression | ISO | RGD:731020 | 6480464 | ferric oxide analog results in increased expression of ADORA2B mRNA | CTD | PMID:25086211 | folic acid | multiple interactions | ISO | RGD:731020 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ADORA2B mRNA | CTD | PMID:20938992 | formaldehyde | decreases expression | ISO | RGD:731019 | 6480464 | Formaldehyde results in decreased expression of ADORA2B mRNA | CTD | PMID:20655997 | furan | increases expression | EXP | | 6480464 | furan results in increased expression of ADORA2B mRNA | CTD | PMID:27387713 | indometacin | multiple interactions | ISO | RGD:731019 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ADORA2B mRNA | CTD | PMID:28628672 | isobutanol | multiple interactions | ISO | RGD:731019 | 6480464 | [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of ADORA2B mRNA | CTD | PMID:29432896 | L-methionine | multiple interactions | ISO | RGD:731020 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ADORA2B mRNA | CTD | PMID:20938992 | lead(0) | affects expression | ISO | RGD:731019 | 6480464 | Lead affects the expression of ADORA2B mRNA | CTD | PMID:28903495 | lead(2+) | affects expression | ISO | RGD:731019 | 6480464 | Lead affects the expression of ADORA2B mRNA | CTD | PMID:28903495 | lipopolysaccharide | decreases expression | ISO | RGD:731019 | 6480464 | Lipopolysaccharides results in decreased expression of ADORA2B mRNA | CTD | PMID:20067761 | lipopolysaccharide | multiple interactions | ISO | RGD:731019 | 6480464 | [S-(1 more ... | CTD | PMID:35811015 | lipopolysaccharide | increases expression | ISO | RGD:731020 | 6480464 | Lipopolysaccharides results in increased expression of ADORA2B mRNA | CTD | PMID:21461237, PMID:25890327 | lipopolysaccharide | multiple interactions | ISO | RGD:731020 | 6480464 | [Lipopolysaccharides co-treated with Melatonin] results in decreased expression of ADORA2B mRNA, Melatonin inhibits the reaction [Lipopolysaccharides results in increased expression of ADORA2B mRNA] | CTD | PMID:21461237 | MeIQx | increases expression | ISO | RGD:731019 | 6480464 | 2-amino-3 more ... | CTD | PMID:20816883 | melatonin | multiple interactions | ISO | RGD:731020 | 6480464 | [Lipopolysaccharides co-treated with Melatonin] results in decreased expression of ADORA2B mRNA, Melatonin inhibits the reaction [Lipopolysaccharides results in increased expression of ADORA2B mRNA] | CTD | PMID:21461237 | melatonin | decreases expression | ISO | RGD:731020 | 6480464 | Melatonin results in decreased expression of ADORA2B mRNA | CTD | PMID:21461237 | methotrexate | increases expression | ISO | RGD:731019 | 6480464 | Methotrexate results in increased expression of ADORA2B mRNA | CTD | PMID:22682496 | modafinil | increases activity | EXP | | 6480464 | modafinil results in increased activity of ADORA2B protein | CTD | PMID:29649498 | N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide | multiple interactions | ISO | RGD:731020 | 6480464 | N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [ADORA2B protein inhibits the reaction [Ethanol results in increased phosphorylation of RELA protein]] | CTD | PMID:35143882 | N-ethyl-5'-carboxamidoadenosine | affects response to substance | ISO | RGD:731020 | 6480464 | ADORA2B protein affects the susceptibility to Adenosine-5'-(N-ethylcarboxamide) | CTD | PMID:16920807 | nickel atom | increases expression | ISO | RGD:731019 | 6480464 | Nickel results in increased expression of ADORA2B mRNA | CTD | PMID:25583101 | nickel sulfate | increases expression | ISO | RGD:731019 | 6480464 | nickel sulfate results in increased expression of ADORA2B mRNA | CTD | PMID:16314067 | nitrogen dioxide | multiple interactions | ISO | RGD:731019 | 6480464 | [Air Pollutants results in increased abundance of Nitrogen Dioxide] which affects the methylation of ADORA2B gene | CTD | PMID:29935799 | ozone | multiple interactions | ISO | RGD:731020 | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of ADORA2B mRNA, [Air Pollutants results in increased abundance of Ozone] which results in increased expression of ADORA2B mRNA | CTD | PMID:34911549 | paracetamol | increases expression | ISO | RGD:731019 | 6480464 | Acetaminophen results in increased expression of ADORA2B mRNA | CTD | PMID:29067470 | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of ADORA2B mRNA | CTD | PMID:33387578 | paraquat | increases expression | EXP | | 6480464 | Paraquat results in increased expression of ADORA2B mRNA | CTD | PMID:32680482 | phenobarbital | affects expression | ISO | RGD:731019 | 6480464 | Phenobarbital affects the expression of ADORA2B mRNA | CTD | PMID:19159669 | pirinixic acid | decreases expression | ISO | RGD:731020 | 6480464 | pirinixic acid results in decreased expression of ADORA2B mRNA | CTD | PMID:17426115 | progesterone | multiple interactions | ISO | RGD:731020 | 6480464 | [Estradiol co-treated with Progesterone] results in increased expression of ADORA2B mRNA | CTD | PMID:19693291 | progesterone | increases expression | ISO | RGD:731020 | 6480464 | Progesterone results in increased expression of ADORA2B mRNA | CTD | PMID:19693291 | propiconazole | decreases expression | EXP | | 6480464 | propiconazole results in decreased expression of ADORA2B mRNA | CTD | PMID:19423681 | raloxifene | multiple interactions | ISO | RGD:731019 | 6480464 | [Raloxifene Hydrochloride co-treated with ESR2 protein] results in increased expression of ADORA2B mRNA | CTD | PMID:19059307 | rotenone | decreases expression | EXP | | 6480464 | Rotenone results in decreased expression of ADORA2B mRNA | CTD | PMID:28374803 | rotenone | increases expression | ISO | RGD:731019 | 6480464 | Rotenone results in increased expression of ADORA2B mRNA | CTD | PMID:29955902 | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | ISO | RGD:731019 | 6480464 | [S-(1 more ... | CTD | PMID:35811015 | SB 431542 | multiple interactions | ISO | RGD:731019 | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | simvastatin | multiple interactions | EXP | | 6480464 | Simvastatin inhibits the reaction [lipopolysaccharide more ... | CTD | PMID:33774062 | sodium dichromate | decreases expression | EXP | | 6480464 | sodium bichromate results in decreased expression of ADORA2B mRNA | CTD | PMID:25993096 | succimer | multiple interactions | ISO | RGD:731020 | 6480464 | [Succimer binds to Magnetite Nanoparticles] which results in increased expression of ADORA2B mRNA | CTD | PMID:21641980 | sulforaphane | increases expression | ISO | RGD:731019 | 6480464 | sulforaphane results in increased expression of ADORA2B mRNA | CTD | PMID:31838189 | sunitinib | increases expression | ISO | RGD:731019 | 6480464 | Sunitinib results in increased expression of ADORA2B mRNA | CTD | PMID:31533062 | tamoxifen | multiple interactions | ISO | RGD:731019 | 6480464 | [Tamoxifen co-treated with ESR2 protein] results in increased expression of ADORA2B mRNA | CTD | PMID:19059307 | temozolomide | increases expression | ISO | RGD:731019 | 6480464 | Temozolomide results in increased expression of ADORA2B mRNA | CTD | PMID:31758290 | tert-butyl hydroperoxide | increases expression | ISO | RGD:731019 | 6480464 | tert-Butylhydroperoxide results in increased expression of ADORA2B mRNA | CTD | PMID:15336504 | testosterone | decreases expression | ISO | RGD:731019 | 6480464 | Testosterone results in decreased expression of ADORA2B mRNA | CTD | PMID:21592394 | testosterone | increases expression | ISO | RGD:731020 | 6480464 | Testosterone results in increased expression of ADORA2B mRNA | CTD | PMID:19693291 | testosterone | multiple interactions | ISO | RGD:731019 | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of ADORA2B mRNA | CTD | PMID:21592394 | tetrachloroethene | increases expression | ISO | RGD:731020 | 6480464 | Tetrachloroethylene results in increased expression of ADORA2B mRNA | CTD | PMID:28973375 | tetrachloromethane | increases expression | ISO | RGD:731020 | 6480464 | Carbon Tetrachloride results in increased expression of ADORA2B mRNA | CTD | PMID:17484886, PMID:18263696 | tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of ADORA2B mRNA | CTD | PMID:31150632 | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of ADORA2B mRNA | CTD | PMID:34492290 | titanium dioxide | multiple interactions | ISO | RGD:731020 | 6480464 | [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] affects the expression of ADORA2B mRNA | CTD | PMID:29950665 | tremolite asbestos | increases expression | ISO | RGD:731020 | 6480464 | tremolite results in increased expression of ADORA2B mRNA | CTD | PMID:29279043 | triadimefon | decreases expression | EXP | | 6480464 | triadimefon results in decreased expression of ADORA2B mRNA | CTD | PMID:19423681 | trichloroethene | increases methylation | EXP | | 6480464 | Trichloroethylene results in increased methylation of ADORA2B gene | CTD | PMID:27618143 | trichloroethene | increases expression | EXP | | 6480464 | Trichloroethylene results in increased expression of ADORA2B mRNA | CTD | PMID:33387578 | trimellitic anhydride | increases expression | ISO | RGD:731020 | 6480464 | trimellitic anhydride results in increased expression of ADORA2B mRNA | CTD | PMID:19042947 | Tungsten carbide | multiple interactions | ISO | RGD:731019 | 6480464 | [tungsten carbide co-treated with Cobalt] results in increased expression of ADORA2B mRNA | CTD | PMID:18078969 | tunicamycin | decreases expression | ISO | RGD:731019 | 6480464 | Tunicamycin results in decreased expression of ADORA2B mRNA | CTD | PMID:22378314 | valproic acid | affects expression | ISO | RGD:731020 | 6480464 | Valproic Acid affects the expression of ADORA2B mRNA | CTD | PMID:17963808 | valproic acid | multiple interactions | ISO | RGD:731019 | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ADORA2B mRNA | CTD | PMID:27188386 | valproic acid | increases expression | ISO | RGD:731019 | 6480464 | Valproic Acid results in increased expression of ADORA2B mRNA | CTD | PMID:24383497, PMID:26272509 | valproic acid | increases methylation | ISO | RGD:731019 | 6480464 | Valproic Acid results in increased methylation of ADORA2B gene | CTD | PMID:29154799 | vinclozolin | increases expression | EXP | | 6480464 | vinclozolin results in increased expression of ADORA2B mRNA | CTD | PMID:15686871 | |